The Current Ratio as of July 2024 (TTM) for PDS Biotechnology Corporation (PDSB) is 4.56

According to PDS Biotechnology Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.56. This represents a change of -21.10% compared to the average of 5.78 of the last 4 quarters.

PDS Biotechnology Corporation (PDSB) Historical Current Ratio (quarterly & annually)

How has PDSB Current Ratio performed in the past?

The mean historical Current Ratio of PDS Biotechnology Corporation over the last ten years is 9.22. The current 4.56 Current Ratio has changed 4.85% with respect to the historical average. Over the past ten years (40 quarters), PDSB's Current Ratio was at its highest in in the September 2016 quarter at 26.60. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

PDS Biotechnology Corporation (PDSB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PDS Biotechnology Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PDS Biotechnology Corporation (PDSB) Average Current Ratio

How has PDSB Current Ratio performed in the past?

The current Current Ratio of PDS Biotechnology Corporation (PDSB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PDS Biotechnology Corporation (PDSB) Current Ratio vs. Peers

How is PDSB’s Current Ratio compared to its peers?

PDS Biotechnology Corporation’s Current Ratio is less than Mereo BioPharma Group plc (0), less than Terns Pharmaceuticals, Inc. (4.86), less than Inozyme Pharma, Inc. (27.85), less than HOOKIPA Pharma Inc. (14.05), greater than eFFECTOR Therapeutics, Inc. (4.50), greater than Enveric Biosciences, Inc. (1.03), greater than CohBar, Inc. (3.48), greater than Ocean Biomedical, Inc. (4.16), greater than AVROBIO, Inc. (0.03), less than X4 Pharmaceuticals, Inc. (26.17), greater than Day One Biopharmaceuticals, Inc. (3.71), less than Elevation Oncology, Inc. (10.93), less than null (46.22),

Build a custom stock screener for PDS Biotechnology Corporation (PDSB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PDS Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PDS Biotechnology Corporation (PDSB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PDS Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.